Walczak H - Search Results

1

Troglitazone-mediated sensitization to TRAIL-induced apoptosis is regulated by proteasome-dependent degradation of FLIP and ERK1/2-dependent phosphorylation of BAD.

Grund K, Ahmadi R, Jung F, Funke V, Gdynia G, Benner A, Sykora J, Walczak H, Joos S, Felsberg J, Reifenberger G, Wiestler OD, Herold-Mende C, Roth W. Grund K, et al. Among authors: walczak h. Cancer Biol Ther. 2008 Dec;7(12):1982-90. doi: 10.4161/cbt.7.12.6966. Cancer Biol Ther. 2008. PMID: 19158480

2

Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes.

Leverkus M, Neumann M, Mengling T, Rauch CT, Bröcker EB, Krammer PH, Walczak H. Leverkus M, et al. Among authors: walczak h. Cancer Res. 2000 Feb 1;60(3):553-9. Cancer Res. 2000. PMID: 10676636

3

Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.

Walczak H, Bouchon A, Stahl H, Krammer PH. Walczak H, et al. Cancer Res. 2000 Jun 1;60(11):3051-7. Cancer Res. 2000. PMID: 10850456

4

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2.

Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J, Krammer PH, Walczak H. Sprick MR, et al. Among authors: walczak h. Immunity. 2000 Jun;12(6):599-609. doi: 10.1016/s1074-7613(00)80211-3. Immunity. 2000. PMID: 10894160 Free article.

5

Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.

Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, Bayer E, Walczak H, Kalthoff H, Ungefroren H. Hinz S, et al. Among authors: walczak h. Oncogene. 2000 Nov 16;19(48):5477-86. doi: 10.1038/sj.onc.1203936. Oncogene. 2000. PMID: 11114725

6

CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.

Röhn TA, Wagenknecht B, Roth W, Naumann U, Gulbins E, Krammer PH, Walczak H, Weller M. Röhn TA, et al. Among authors: walczak h. Oncogene. 2001 Jul 12;20(31):4128-37. doi: 10.1038/sj.onc.1204534. Oncogene. 2001. PMID: 11464279

7

CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells.

Trauzold A, Wermann H, Arlt A, Schütze S, Schäfer H, Oestern S, Röder C, Ungefroren H, Lampe E, Heinrich M, Walczak H, Kalthoff H. Trauzold A, et al. Among authors: walczak h. Oncogene. 2001 Jul 12;20(31):4258-69. doi: 10.1038/sj.onc.1204559. Oncogene. 2001. PMID: 11464292

8

TRAIL enhances thymidine kinase/ganciclovir gene therapy of neuroblastoma cells.

Beltinger C, Fulda S, Walczak H, Debatin KM. Beltinger C, et al. Among authors: walczak h. Cancer Gene Ther. 2002 Apr;9(4):372-81. doi: 10.1038/sj.cgt.7700448. Cancer Gene Ther. 2002. PMID: 11960288

9

Apoptosis induction by TRAIL.

Eggert A, Sieverts H, Walczak H. Eggert A, et al. Among authors: walczak h. Methods Mol Biol. 2003;215:95-116. doi: 10.1385/1-59259-345-3:95. Methods Mol Biol. 2003. PMID: 12512293 No abstract available.

10

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.

Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H. Ganten TM, et al. Among authors: walczak h. Cell Death Differ. 2004 Jul;11 Suppl 1:S86-96. doi: 10.1038/sj.cdd.4401437. Cell Death Differ. 2004. PMID: 15105837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters